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ABSTRACT
Allergies have the potential to be a life-long debilitating fight, especially the severe
reactions from allergies such as anaphylaxis. Peanut allergies tend to be both common and
severe, and they happen to be found hiding in many food products. People can have allergic
reactions to food products that were made in the same facility as peanut products, that is why it is
so important to be aware of the products that are being consumed. The incidence of peanut
allergies has increased in the last decade, which is why it is crucial to study these allergies. This
thesis looks at when the best time is to introduce peanut products to young children and the
common risk factors that are associated with peanut allergies in children. The risk factors that are
being looked at include: genetics, socioeconomic status, and ethnicity. This thesis also
investigates a couple of treatment options for if your child develops a peanut allergy.
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INTRODUCTION
Peanut allergies are very common and widely misunderstood. “The Center for Disease
Control and Prevention reports the prevalence of food allergy in children has increased by 50%
between 1971 and 2011” (Food Allergy and Research Education, 2017, p. 1). In fact, studies
have shown the number of peanut allergies has tripled in the past decade, evident in both
Western and developing countries (Fleischer et al., 2015). Peanut allergies are a well-known
topic of research because the reactions related to them are very severe. According to Anvari et al.
(2017), “peanuts account for the most food-induced anaphylaxis and fatal reactions” (p. 77). As a
result, parents are becoming increasingly worried about their children potentially developing this
life-threatening allergy. This is leading to many research studies being conducted to link certain
risk factors with the development of peanut allergies. Over the years, the recommendations and
guidelines developed by the American Academy of Pediatrics (AAP) have changed drastically
regarding peanut exposure. In less than a decade the guidelines have completely shifted.
Due to the severity of peanut allergies, many parents have stopped introducing peanuts
into their children’s diet and decided to wait years for their children to come into contact with
peanuts (Anvari et al., 2017). The 1999 AAP guidelines recommended that parents delay
introducing peanuts to their children. There were also recommendations that associated maternal
exposure to these allergens with an increased incidence of peanut allergies in children.
Therefore, parents were hoping that by avoiding peanuts in the womb, early infancy, and
childhood they would reduce the chances of their child becoming intolerant to peanuts.
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Unfortunately, the result of this practice led to a rapid increase in peanut allergies. In 2008, new
guidelines from the AAP recommended introducing peanuts during early infancy. As a result,
there have been studies conducted to reinforce these new guidelines. Studies conducted since the
introduction of these guidelines suggest there is no relationship between maternal exposure and
the risk of peanut allergy in children (Anvari et al., 2017).
Genetics also appears to play a role in the formation of peanut allergies in children. Firstdegree relatives are very genetically similar and carry similar risks for many health concerns. If
someone in a family is genetically predisposed to acquiring a peanut allergy, are the remaining
family members at risk? Children are considered as “high risk” for acquiring an allergy if a firstdegree family member has an allergy to the nut (Anvari et al., 2017). A study conducted by
Bégin, Graham, Killer, Paradis J, Paradis L, and Des Roches (2016) linked the siblings of
children to peanut allergies with a higher risk of developing a serious reaction to peanuts. It also
concluded that due to one child in the family having an allergy, the parents neglected the
introduction of the allergen to the rest of the siblings. This resulted in the allergy being more
severe due to the delayed introduction. According to another study by Lavine, et al. (2014),
parents neglected to introduce the siblings of children with a peanut allergy to peanuts under the
assumption they would also have a sensitivity reaction. This was especially prevalent in families
that had a subsequent child after the original diagnosis of a peanut allergy in their older child.
This further contributes to the increase in prevalence of peanut allergies due to these parents
delaying the children’s exposure to peanuts.
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The third aspect of peanut allergies this literature review is going to address is the
characteristics of the children that are most commonly seen with peanut allergies. Do children of
a certain race, ethnicity or socioeconomic status have a higher incidence of peanut allergies?
Hannaway, Connelly, Cobbett, and Dobrow (2005) conducted a study in Massachusetts where
they collected data on who they were administering the most epinephrine injections for certain
allergies based on three school districts one urban and two affluent suburban districts. They
found that Caucasian students from kindergarten to fifth grade had the most epinephrine
injections over the course of the year (Hannaway et al., 2005), suggesting a higher prevalence of
allergies in Caucasian children of higher socioeconomic status. Another study by Leickly,
Kloepfer, Slaven, and Vitalpur (2013) looked into the epidemiology of children that had a
hypersensitivity to peanuts. This study followed over 1070 children that showed peanut
sensitivity signs. Over the course of the two-year study, the researchers noted that children that
had an allergy were “predominantly male (63%), Caucasian (78%), and had private health
insurance (80%)” (p. 253). They also concluded that children experiencing anaphylaxis reactions
to peanuts had higher IgE levels in their blood.
The last aspect this literature review will focus on are the most effective treatments for
children that have already established a peanut allergy. The most important method for managing
peanut allergies is prevention. It is extremely important to be aware of products that contain
peanuts, especially products that have less visibility such as sauces, ice creams, and chilis.
Another treatment that has been effective is early oral therapy. Vickery, Berglund, and Berk
(2018) looked at oral therapy treatment for children with peanut sensitivity or allergy. They
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introduced low dose peanut protein to these children over a certain amount of time, and followed
their IgE levels throughout the study and concluded this is an effective way to desensitize
children and allow them to build up a tolerance. Another treatment that Jones, Sicherer, and
Burks (2017) studied was epicutaneous immunotherapy among children allergic to peanuts. This
study consisted of three groups: one placebo and two independent groups receiving different
dosages of peanut proteins through a patch on their arm. The study was conducted over fifty-two
weeks, and the participants were able to tolerate higher doses as the study went on. The treatment
had higher success among younger participants in the study.
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BACKGROUND
Most people refer to peanuts as a tree nut, but that is not true. According to Food Allergy
Research and Education (2018), peanuts come from the ground and are members of the legume
family. In addition, an allergy to peanuts does not make someone any more susceptible to
acquiring another legume allergy. When someone reacts to peanuts, they are told to avoid them,
but there are other specific products the person needs to avoid. Products or ingredients such as
peanut oil, groundnuts, peanut flour, and nutmeat consist of peanuts and can cause someone to
produce an allergic reaction. It is important to read food labels closely to determine if the food
product contains remnants of peanuts or was produced in a facility near products containing
peanuts. Peanuts are present in many products or produced in factories that also produce other
food products. Therefore, it is important that people with peanut allergies are aware of these
risks and conscientious of the products they are consuming.
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PURPOSE
The main issue with peanut allergies is they tend to be very severe and common.
“Pediatric hospitalizations for food allergies tripled between the late 1990s and mid-2000s.
Between 2004 and 2006, an average of 9,500 people/children received hospital care for food
allergies each year” (FARE, 2017, p. 2). This literature review is proposing to identify the risk
factors that are associated with long-term childhood peanut allergy development. It will also
identify any developing patterns with the new increasing prevalence of allergies to peanuts such
as time of introduction, SES, and genetics. It will evaluate a variety of treatment options that are
available to reduce the severity of the peanut allergy once it is established. Lastly, the final
literature review will examine these factors and go into depth regarding the findings of the
studies listed. It will also highlight the most effective treatments and the newest guidelines by the
American Academy of Pediatrics regarding peanut allergies in children. The purpose of this
literature review is to identify high-risk groups, target these populations, and find out why this is
occurring and find a solution to the problem.

6

METHOD
The initial searches for the literature review were done by going online to the UCF
library database. I searched for articles on CINAHL, EBSCOhost, Cochrane, and Medline
databases using the terms PEDI* or PAED* or child* or children*, peanut allerg*, anaphylaxi*.
For each point, I used the above criteria along with “genetics”, “socioeconomic status”, and
“treatments”. I also searched the above criteria with “treat*” or “cure” to find common ways to
treat peanut allergy reactions. The articles were then narrowed down further by only using peerreviewed articles that were written in English and published no earlier than 2010. Once several
articles were viewed, assessed and deemed appropriate, they were placed and organized into a
reference table based on the points they were used for and relevance to the literature review.
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REVIEW OF LITERATURE
When to Introduce
In 1999 the AAP came up with their set of guidelines for peanut products they believed
would reduce the incidence of peanut allergy formation in children (Anvari et al., 2017). These
guidelines stated that in order to put children at less risk of developing peanut allergies, parents
should delay the introduction of peanuts in infancy and early childhood. The incidence of peanut
allergies began to rise (Anvari et al., 2017) studies have been done to determine why there is an
increasing incidence of peanut allergies and new guidelines have been released to combat these
allergies. A significant study was conducted in 2015 by the New England Journal of Medicine
called the LEAP (Learning Early About Peanut Allergy) trial that looked more in-depth at when
to introduce peanut products.
Lisette Hilton (2017) wrote a journal article that discussed several medical doctors’ views
on the ever-changing peanut guidelines. Bernard Cohen, an MD from John Hopkins University
School of Medicine says, “Many of us were concerned about delaying exposure to all sorts of
allergens, the idea being that, if kids are exposed early on, they become tolerant and do fine” (p.
36). Lawrence F. Eichenfield, MD specializes in pediatric dermatology and has noticed the
connection between children who have atopic dermatitis and developing food allergies. He
served on the board for the newest set of guidelines on behalf of the American Academy of
Dermatology (AAD) and supported the notion that children with skin conditions should be
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exposed early to certain foods prone to create severe allergies to minimize the risk of developing
an allergy.
Eichenfield further discusses the best method for introducing peanuts to infants because
there is a high aspiration risk if a child is simply given a peanut to chew on (Hilton, 2017).
“Cohen recommends a product called Bamba, a snack made in Israel, by Osem Group, for safe
exposure” (p. 38) An Israeli news source, Haaretz, wrote an article about Bamba. It discussed
how Israeli children have a significant amount of less peanut allergies than Westernized children
with similar ethnicities. “One reason could be early exposure to peanuts by eating (and teething
on) Bamba, a peanut-flavored snack considered a staple of Israeli childhood” (p. 38). Cohen also
states that many of these introductions should be done for the first time in a pediatrician’s office
to be monitored.
Peter Lio, MD is a slight critic of these new guidelines. He believes there needs to be
more research done. The guidelines were based on the LEAP Trial and may not serve as the best
recommendation for every child (Hilton, 2017). He also believes that one doctor’s definition of
“severe atopic dermatitis” may differ from another, making treatment regimens inconsistent.
In summary, current studies have shown favorable results regarding early introduction of
peanuts in children. These new recommendations highly contradicted the previous guidelines,
but had more research studies behind it backing it up. Hopefully, future studies will be done to
further this research and will continue to reduce the numbers of peanut allergies in children.
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Genetic Component
Another important factor to consider in the development of peanut allergies is a genetic
component. It is important to recognize any similarities or patterns that evolve around a family
unit regarding peanut allergies. If researchers can identify a genetic component between family
members, it may lead to new advancements, which could reduce the overall peanut allergy
prevalence in the population.
Lavine et al. (2014) conducted a study called the Canadian Peanut Allergy Registry
(PAR). “This study looked at nine hundred and twenty-two siblings of children that have
developed a peanut allergy” ( p. 249-254). They sent these families a questionnaire based “on
siblings’ sociodemographic characteristics, exposure and reactions to peanut, confirmatory tests
performed, and whether peanut allergy had been confirmed” (p. 249-254). “Of the peanut
allergic siblings, 13.6% had never been exposed to peanut, 764 had been exposed, and 33 were
uncertain. Among those never exposed, the majority (n = 88/125) was born after the diagnosis of
peanut allergy (PNA) in the index child. Of the sibling group, 8.7% reported having been
diagnosed with peanut allergy by a physician. Among these 80 children, 41 (51.3%) had reacted
to peanut, 34 (42.5%) had never reacted, and in 5 children, the parents were not sure” (p. 249254). The study showed that a significant number of children that were born after their sibling
had been diagnosed with a peanut allergy, would be delayed the opportunity to try peanut
products if the parents chose. The study concluded that siblings of children with peanut allergies
have a slightly higher risk of developing a similar allergy (7%) verses children that do not have a
sibling with a peanut allergy (1%).
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Bégin et al. (2016) conducted a similar double-blind study where fifty-four children that
had older siblings with peanut allergies had skin testing done and then were introduced to
peanuts. The results showed that “eight participants (5.2%) presented unequivocal IgE‐mediated
reactions to peanut upon introduction, including five anaphylaxes. These participants were
significantly older compared to the rest of the cohort. The negative predictive value of skin prick
test with peanut extract and peanut butter and of specific IgE was 99%, 100%, and 100%,
respectively. Six peanut‐tolerant participants had positive peanut allergy tests” (p. 1762-1771).
The conclusions were similar to Lavine et al.’s (2014) study, where there is a higher risk of
children with peanut allergic siblings to acquire a peanut allergy.
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Common Characteristics of Children with Peanut Allergies
This component aims to identify common characteristics of children with peanut
allergies. If these characteristics can be identified and proven, pediatricians can target these
specific populations in hopes to reduce severe allergic reactions.
Hannaway et al. (2005) studied three suburban school districts. They collected data from
these districts, specifically focusing on the number of times the school children were injected
with epinephrine to combat an allergic reaction. They also looked at specific characteristics of
the children: ethnic status, race, socioeconomic status. Of the 181 students that were injected
with epinephrine over the course of the trial period, 118 of these were treated due to a tree
nut/peanut allergy. In children that had the tree nut, or peanut allergy, there was a higher
incidence of white males receiving the epinephrine injections. Further research needs to be done
to see why this is the case. It may have something to do with a certain number underdiagnosed or
untreated children, which could be affected by other factors such as socioeconomic status.
Leickly et al. (2018) conducted an epidemiological study that also included the same
components. The sample consisted of children from 3 facilities in Indiana who had a peanut
allergy or sensitization called the Riley Peanut Registry that began in 2011. “Peanut allergy was
defined based on a convincing history of a reaction within 2 hours after exposure to peanut either
by ingestion or by contact and the presence of a positive allergy test.” (p. 224) Sensitization to
peanuts was defined as “having a skin prick test >3 mm bigger than the negative control. Or, for
those children who were seen prior to adopting caliper measurements, a wheal of 3-4+ size
and/or the presence of detectable IgE to peanut, but no clinical history of a reaction” (p. 224).
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The Leickly et al. (2018) study showed that of the 1070 children that were in the study,
67% had an official allergy, and 33% had a sensitivity. This is a consistent ratio found in other
studies. The results are shown in Table II. They indicate that peanut allergies are more common
in males with skin reactions to the peanut being the most common finding. Also, peanut allergies
are more common in siblings, Caucasians, and in children with private health insurance.

Figure 1

(Leicky et al., 2018, p. 225)
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Treatments
Now that these guidelines have been posted to prevent raising the risk of peanut allergy
formation, what should be done if a child does develop a potentially life-threatening reaction to
peanuts? As a parent, it is frightening knowing their children are being exposed to peanuts
regularly in products that might not knowingly contain peanuts. So, it is important to identify
ways to deescalate a severe allergic reaction.
There are a couple treatment options that are available depending on the severity of the
allergy. One of the treatments that is currently being studied is desensitization therapy. There
was a study done by Anagnostou, Islam, King, Foley, Pasea, Bond, Palmer, Deighton, Ewan, and
Clark (2014) that looked at exposing children with an allergy to peanuts to peanut flour. People
that had an immediate hypersensitivity reaction to peanuts and/or tested positive to a skin prick
tests were eligible for this treatment. There were three phases, each phase consisted of a certain
amount of peanuts ingested. The first phase consisted of 800 mg of peanut ingestion per day, and
the second phase was about 1400 mg peanuts per day, etc. After only the first phase, 62% of the
control group was desensitized to peanuts. This research is relatively newer and is a step in the
positive direction of treatment home for those with severe peanut allergies.
Another treatment option that is available if your child develops a severe reaction suddenly is an
epinephrine subcutaneous injection, aka “The Epi Pen”. The idea behind this treatment is that
when a child has a severe allergic reaction, they are able to inject a subcutaneous dose of
epinephrine that will suppress the inflammatory response and reduce the severity of the reaction.
“Guidelines uniformly agree that its prompt administration is vital to prevent progression,
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improve patient outcomes, and reduce hospitalizations and fatalities” (Fromer, 2016, p. 1244).
Epinephrine was not always readily accessible to these children, but in recent years they have
been available in a “pen” form that children are able to carry around with them if their allergy is
severe. A lot of times the injection is kept in the school nurse’s office so it is available to the
child while they are at school. It also requires a lot of teaching for the child and their family,
such as how to safely inject and store the medication. This provides a better peace of mind to
both the parent and child for when they come into contact with the allergen, it also hopes to
reduce the incidence of fatal allergic outcomes.
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DISCUSSION
The theory about peanuts has changed greatly over the last 20 years. In 1999 the AAP
released guidelines recommending that parents delay the introduction of peanuts to their infant
children, hoping to reduce the prevalence of peanut allergies. Shortly after this, there was a slight
rise in the incidence of peanut allergies, sparking concern. The most recent guidelines that were
released by the National Institute of Allergy and Infectious Disease (NIAID) included specific
recommendations that incorporate the high-risk status of the infant towards a peanut allergy and
when to introduce peanuts (Table II) based on their study, the LEAP trial.
One thing to keep in mind when looking at these changing guidelines is that every child
is different. These guidelines keep adjusting, so it is important to research the studies that
support these new regulations. Peanut allergies are life-threatening and due to their severity have
a tendency to produce anaphylactic reactions. Therefore, it is important to know the signs and
symptoms of an allergic reaction such as, “laryngeal edema, wheezing, nausea, vomiting,
diarrhea, urticaria, angioedema, and hypotension” (Patel & Volcheck, 2015, p. 1).
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RECOMMENDATIONS FOR PRACTICE
The National Institute of Allergy and Infectious Diseases (NIAID) has come up with
specific guidelines for providers introducing peanut products to high-risk infants with rationale
supporting each claim. The NIAID released guidelines in 2010 but did not offer definitive
strategies to prevent peanut allergies due to the lack of studies done on the topic. In 2017 they
released a new set of guidelines with specific recommendations and rationales. This is intended
for providers to use in their practice. With only a few guidelines to follow, it creates a standard
of care across the board (Togias et al., 2017).
The New England Journal of Medicine conducted their own study in 2015 called the
Learning Early About Peanut Allergy (LEAP) trial when they noticed a significantly higher
peanut allergy rate in children from United Kingdom verses Israel (Togias et al., 2017). They
looked into this further and concluded that it might have something to do with Israel introducing
peanuts early into the diets of infant children, while the United Kingdom typically waits to
introduce peanuts. The LEAP trial was conducted based on these observations.
“The LEAP trial randomized 640 children between 4 and 11 months of age with severe
eczema, egg allergy, or both to consume or avoid peanut-containing foods until 6 months of age,
at which time a peanut oral food challenge (OFC) was conducted to determine the prevalence of
peanut allergy” (Togias et al., 2017, p. 2). They performed a skin prick test on these infants to
determine their allergy status. The infants that tested negative were tested separately from the
infants that tested positive. Of the 530 participants that originally had a negative reaction to the
baseline skin test, the amount of participants that developed an allergy at 6 months of age in the
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group that avoided peanuts was 13.7%, while the amount of participants that consumed peanuts
only 1.9% developed an allergy. Among the infants that tested positive to the baseline skin test in
response to peanuts, the prevalence of peanut allergies was about 35% in the infants that delayed
introduction to peanuts, and about 11% in the infants that were exposed to peanuts early.
The NAID formulated committees to conduct a literature review on this topic from 2010
to 2016. With the research, they were able to formulate new guidelines for 2017 (Table I).

Figure 2

(Togias et al., 2017)
The guidelines define the infant criteria as: “Severe eczema is defined as persistent or frequently
recurring eczema with typical morphology and distribution assessed as severe by a health care
provider and requiring frequent need for prescription-strength topical corticosteroids, calcineurin
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inhibitors, or other anti-inflammatory agents despite appropriate use of emollients” (p. 4) They
also defined an egg allergy as having a skin reaction of a wheal diameter of at least 3 mm or
larger in response to an egg skin prick test (SPT) or an allergy to an oral dose of egg (Togias et
al., 2017).
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